GN Store Nord

GN Store Nord reported an adjusted EBITA of DKK 110 million for Q2 with an adjusted EBITA margin of 5%, while organic revenue in the continuing business declined by 4%. Free cash flow excluding M&A was negative at DKK -616 million, weighed down by a temporary build-up of working capital from internalizing the supply chain. Management raised the margin outlook for 2026 to 9–10% but narrowed the revenue forecast to the lower half of the range and expects a recovery in the second half of the year supported by ReSound Sensia and product launches. The sale of the hearing-aids segment to Amplifon is still expected by the end of 2026; the stock fell by around 4.85%. » Mere på de.investing.com

GN Store Nord reported declining revenues in continuing operations for Q1 2026 (DKK 2,096m, -8% yoy) and an adjusted EBITA margin of only 0.3% after one-off costs of DKK 404m related to the spin-off of the hearing-aid unit. The Enterprise division suffered from regional weakness in EMEA, while premium headsets (Evolve3) and gaming products showed growth. The sale of the hearing-aid business to Amplifon remains on track for completion by end-2026; post-close excess cash of DKK 3.5–4.5bn and a share buyback program are expected. GN affirmed its 2026 guidance (organic revenue growth 0–6%, adjusted EBITA margin 8–9%) despite significant restructuring and impairment charges in 2026–2027. » Mere på de.investing.com

Board member Tsaligopoulos sold a total of 2,500 audius shares on January 27, 2026 — 1,000 and previously 1,500 from his own holdings — each at €12.80. The stock last traded on the FSE at about €12.50. audius has a market capitalization of around €62.49 million; 4,920,723 shares are publicly traded. » Mere på finanzen.net